Russia Prospecting India’s Partnership for Producing the Vaccine

Russia Prospecting India’s Partnership for Producing the Vaccine

NEW DELHI: Russia is considering a partnership with India for producing  Covid-19 vaccine Sputnik V, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), said on Thursday.

As all over the world corona becomes a grave concern now many countries are going to launch their vaccine to win the battle with coronavirus. More than 150 possible vaccines are being developed and tested around the world, including in India, Britain, China, the US, Russia and Israel, to try to control the pandemic.

Several companies, including Moderna, AstraZeneca, and Pfizer Inc, say they expect to make more than 1 billion doses of a vaccine each by next year.

Russia is also in the row. They are going to announce the world’s first vaccine against COVID-19. However, World Health Organisation set Russia’s vaccine on the row of first trials.

Russian President Vladimir Putin had announced that his country has developed the world’s first vaccine against COVID-19. Which works “quite effectively” and forms a “stable immunity” against the disease.

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology. Which is also known as the Gamaleya Scientific Research Institute or Gamaleya National Research Center for Epidemiology and microbiology.

This is the  Russian medical research institute. Headquarter of Gamaleya Research Institute is in Moscow and Ministry of Health of the Russian Federation.

The institute was founded in 1891 by Felix Blyumental and was named after the prominent Russian scientist   Nikolay Gamaleya who was along with the RDIF.

The vaccine has not been verified in Phase 3 or larger clinical trials. This steps must be taken for the security and validity of vaccine.

Leave a Reply

%d bloggers like this: